Chipscreen Biosciences, Ltd.
Clinical trials sponsored by Chipscreen Biosciences, Ltd., explained in plain language.
-
Scientists test new diabetes pill formula on healthy volunteers
Disease control Not yet recruitingThis study aims to see if a new extended-release pill containing two diabetes drugs (chiglitazar and metformin) works the same way in the body as a reference version. It will involve 24 healthy volunteers who will take each pill once during the study. The main goal is to compare …
Phase: NA • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Four-Drug attack on deadly pancreatic cancer enters final testing
Disease control Not yet recruitingThis large, late-stage study is testing whether adding two new drugs (chiauranib and toripalimab) to standard chemotherapy works better for people with advanced pancreatic cancer that has spread. About 558 adults who have not yet received treatment for their metastatic cancer wil…
Phase: PHASE3 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC